![](https://si-interactive.s3.amazonaws.com/prod/ai-cio-com/wp-content/uploads/2024/01/08100537/CIO-010824-10-Predictions-for-2024-in-Memory-of-Byron-Wien-1161949872-web-200x140.jpg)
Risk
10 Predictions for 2024, in Memory of Byron Wien
JPM’s Cembalest gives prophecy a try in a tribute to the late market sage.
JPM’s Cembalest gives prophecy a try in a tribute to the late market sage.
J.P. Morgan strategist Jared Gross sketches out how small life sciences firms are now well-placed due to higher federal research funding and a more receptive FDA.
Recovery stocks are the place to be, says hedge fund chief, in contrast to his jeremiads of 2020.
The S&P 500’s happy days are numbered, with investors blind to Washington overreach, says Michael Hartnett.